MedPath
NMPA Approval

Naloxone Hydrochloride Injection

国药准字H20249399

November 15, 2024

Drug Information

盐酸纳洛酮注射液

注射剂

2ml:2mg

化学药品

November 15, 2024

Company Information

Applicant Company

浙江省金华市东阳市六石街道科技孵化中心甘溪东街888-5号

Manufacturing Company

浙江省东阳市江北高科技工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸纳洛酮注射液 - NMPA 批准文号 | MedPath